Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Key Players companies in Enzalutamide
by Most News Heat in the Switzerland in 2020

The Enzalutamide top 5 is Discovery PatSnap’ annual ranking of the top 5 Most News Heat Enzalutamide Key Players in the Switzerland. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Enzalutamide is used to treat men with a certain type of prostate cancer.

Key Players

Fast-growings

Startups & Unicorns

New Entrants

Ranking Year:

2022

2021

2020

2019

2018

Region:

Global

China

Japan

United States

United Kingdom

France

Switzerland

Germany

Canada

Sweden

Netherlands

Israel

Spain

Ranking:

Most Market Reports

Most News Heat

#
Company Name
Region
Tech Topics
Total
1
Novartis AG
Basel-Stadt, Switzerland
Dosage form,Health care,Medicine,
...[+2]
news: 27
2
Roche Holding AG
Basel-Stadt, Switzerland
Drug,Clinical chemistry,Medicine,
...[+2]
news: 25
3
Novartis Venture Funds
Basel-Stadt, Switzerland
Venture capital,Pharmacy and Therapeutics,Oncogene,
...[+2]
news: 3
4
Credit Suisse Group AG
Zürich, Switzerland
Investment banking,Asset management,Private banking,
...[+2]
news: 2
5
CTC Analytics AG
Basel-Stadt, Switzerland
Automation,Phospholemman,Petroleum industry,
...[+2]
news: 1

Who we serve

R&D Decision MakersNew Product Innovation LeaderTechnology Research AnalystsBusiness Development Professionals

Why Discovery

Technology Intelligence Data FoundationAI-powered Competitive Intelligence RadarTechnology Classification and Company Innovation Indicators

Social media

Try Discovery

Free Trial
PatSnap group products
Browse By:ABCDEFGHIJKLMNOPQRSTUVWXYZ#All topics,List of companies,Sitemap
© 2023 PatSnap. All rights reserved.Legal | Privacy policy Modern Slavery Act Transparency Statement
Page generation time: Jun 26 2025
For better visiting experience, please use PC device.X